CVSA vs BFAM Stock Comparison

Covista and Bright Horizons Family Solutions Prices as of Nov 13, 2026 Peers: Industry group
CVSA Covista Inc.
$118.20 -8.7% 1M +22.8% 1Y
Market cap
$3.99B
P/E
15.5x
Revenue (TTM)
$2.00B
Div. yield
–
Education Services Consumer Discretionary
9 wins

Head to Head

10 decided of 12

Covista leads on 9 of the 12 questions below (Covista 9, Bright Horizons Family Solutions 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCVSABFAMLeader
Larger companyMarket capitalisation $3.99B $2.55B CVSA
Cheaper on earningsLower P/E, profitable companies only 15.5x -19.0x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 13.7x 10.1x BFAM
Faster revenue growthRevenue growth, trailing twelve months +9.3% +6.7% CVSA
More profitableNet margin, trailing twelve months 12.8% -4.4% CVSA
Better return on capitalReturn on invested capital 15.3% 0.1% CVSA
Less leveragedLower net debt / EBITDA 0.6x 12.3x CVSA
Higher dividend yieldTrailing dividend yield 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +22.8% -47.4% CVSA
Better 5-year returnAnnualised price return, 5 years +29.2%/yr -17.6%/yr CVSA
Less volatileAnnualised volatility, 1 year 43.6% 49.3% CVSA
Higher overall scoreMean of the five percentile scores vs peers 68/100 31/100 CVSA

Percentile Scorecard

CVSABFAM

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCVSABFAM
Valuation 46 #20 of 36 29 #26 of 36
Growth 81 #7 of 33 9 #30 of 33
Profitability 84 #6 of 32 16 #27 of 32
Financial Health 49 #21 of 40 3 #39 of 40
Shareholder Returns 82 #4 of 18 100 #1 of 18
Overall 68 31
  • CVSA ranked among 40 companies in Consumer Services
  • BFAM ranked among 40 companies in Consumer Services

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCVSABFAMSPY
1 month -8.7%-23.0% -2.0%
3 months -10.5%-26.1% -2.8%
6 months -3.8%-23.1% +2.0%
Year to date +14.2%-48.0% +10.6%
1 year +22.8%-47.4% +12.2%
3 years +110.4%-39.7% +68.1%
3 years, per year +28.2%-15.5% +18.9%
5 years +259.3%-61.9% +61.4%
5 years, per year +29.2%-17.6% +10.1%
10 years +324.4%-26.5% +248.5%
10 years, per year +15.6%-3.0% +13.3%

Risk

MeasureCVSABFAMSPY
Volatility, 1Y 43.6%49.3% 13.6%
Downside volatility, 1Y 47.5%61.8% 13.9%
Beta vs S&P 500, 1Y 0.25-0.05 1.00
Return / volatility, 1Y 0.52-0.96 0.90
Max drawdown, 5Y -42.1%-63.2% -25.4%
From 52-week high -16.2%-49.6% -3.2%
52-week high $141.00$104.52 $779.14
52-week low $89.36$51.77 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCVSABFAM
P/E now vs peer median 15.6xmedian 12.9x -19.0xmedian 12.9x
P/S now vs peer median 2.0xmedian 1.1x 0.8xmedian 1.1x
EV/EBITDA now vs peer median 9.4xmedian 8.3x 37.5xmedian 8.3x
P/FCF now vs peer median 11.2xmedian 10.7x 10.0xmedian 10.7x
P/B now vs peer median 2.8xmedian 1.8x 4.0xmedian 1.8x
PEG now vs peer median 0.35median 0.25 0.33median 0.25

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCVSABFAM
Revenue $2.00B $3.07B
Gross profit $1.15B $699.13M
Operating income $395.93M $3.13M
Net income $257.16M -$134.21M
Free cash flow $355.17M $253.30M
EPS (diluted) $7.44 $-2.77
Cash & equivalents $222.22M $119.23M
Total debt $500.23M $1.36B
Shares (diluted) 34.57M 48.43M
Enterprise value $3.16B $1.99B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCVSABFAM
P/E 15.6x -19.0x
P/FCF 11.2x 10.0x
P/Operating cash flow 8.7x 7.1x
P/S 2.0x 0.8x
P/B 2.8x 4.0x
P/Tangible book 5.9x 5.6x
EV/EBITDA 9.4x 37.5x
EV/EBIT 10.7x 1,208x
EV/Revenue 2.1x 1.2x
EV/FCF 12.0x 14.9x
EV/Operating cash flow 9.3x 10.6x
PEG (3Y EPS CAGR) 0.35 0.33

Growth

14 metrics
MetricCVSABFAM
Revenue growth (1Y) 9.3% 6.7%
Revenue CAGR (3Y) 11.0% 9.6%
Gross profit growth (1Y) 9.8% 0.5%
Gross profit CAGR (3Y) 12.5% 9.9%
Operating income growth (1Y) 11.0% -99.0%
Operating income CAGR (3Y) 31.9% -74.2%
Net income growth (1Y) 1.8% -166.9%
Net income CAGR (3Y) 34.3% -52.5%
EPS growth (1Y) 9.1% -179.3%
EPS CAGR (3Y) 44.8% -56.8%
Operating cash flow growth (1Y) 19.9% 10.1%
Operating cash flow CAGR (3Y) 31.8% 17.7%
Free cash flow growth (1Y) 10.0% 9.0%
Free cash flow CAGR (3Y) 29.7% 23.1%

Profitability

14 metrics
MetricCVSABFAM
Gross margin 57.4% 22.8%
EBITDA margin 22.6% 3.3%
Operating margin 19.8% 0.1%
Pretax margin 17.9% -1.7%
Net margin 12.8% -4.4%
FCF margin 17.7% 8.3%
Operating cash flow margin 22.7% 11.6%
Return on equity 17.9% -17.0%
Return on assets 8.7% -3.7%
Return on invested capital 15.3% 0.1%
Return on capital employed 17.3% 0.1%
Asset turnover 0.7x 0.8x
Cash conversion (OCF / net income) 1.8x -2.7x
Stock comp / revenue 2.1% 1.0%

Financial Health

11 metrics
MetricCVSABFAM
Debt / assets 17.1% 39.2%
Debt / equity 0.4x 2.1x
Net debt / EBITDA 0.6x 12.3x
Debt / FCF 1.4x 5.4x
Liabilities / assets 51.5% 81.7%
Equity / assets 48.5% 18.3%
Interest coverage 8.9x 0.1x
Current ratio 0.8x 0.4x
Quick ratio 0.7x 0.4x
Cash ratio 0.3x 0.1x
Altman Z-score 4.14 1.50

Shareholder Returns

7 metrics
MetricCVSABFAM
Dividend yield – –
Net buyback yield 7.8% 26.8%
Shareholder yield 7.8% 26.8%
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCVSABFAM
Forward P/E 13.7xFY2027 10.1xFY2026
EPS, next fiscal year $8.65FY2027 $5.20FY2026
EPS growth, next FY +4.8%FY2027 +14.3%FY2026
EPS growth, the year after +24.9% +11.3%
Revenue, next fiscal year $2.12BFY2027 $3.00BFY2026
Revenue growth, next FY +9.0%FY2027 +2.3%FY2026
Revenue growth, the year after -1.0% +0.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCVSABFAM
Held by institutions 98.0% 100.0%
Institutions holding 377 386
Change in shares held, QoQ +0.0% -1.2%
Institutions buying 201 205
Institutions selling 131 150
Buyers to sellers 1.53 1.37

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CVSABFAM
CVSA 1.00 0.25
BFAM 0.25 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CVSA and BFAM?

Covista (CVSA) is the largest by market capitalisation: Covista (CVSA) $3.99B, Bright Horizons Family Solutions (BFAM) $2.55B.

Which company is growing faster?

Covista (CVSA) grew revenue fastest over the trailing twelve months: Covista (CVSA) +9.3%, Bright Horizons Family Solutions (BFAM) +6.7%.

Which company is more profitable?

Covista (CVSA) has the highest net margin (Covista (CVSA) 12.8%, Bright Horizons Family Solutions (BFAM) -4.4%). On return on invested capital, Covista (CVSA) leads (Covista (CVSA) 15.3%, Bright Horizons Family Solutions (BFAM) 0.1%).

Which stock has performed better?

Over the past year Covista (CVSA) returned the most: Covista (CVSA) +22.8%, Bright Horizons Family Solutions (BFAM) -47.4%. Over five years, Covista (CVSA) compounded fastest (Covista (CVSA) +29.2%/yr, Bright Horizons Family Solutions (BFAM) -17.6%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Covista (CVSA) has been the steadiest (Covista (CVSA) 43.6%, Bright Horizons Family Solutions (BFAM) 49.3%). Volatility measures how widely the price swings, not the risk of the business.

Do CVSA and BFAM move together?

Their daily returns over the past year have a correlation of 0.25, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, CVSA and BFAM?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Covista (CVSA) leads on 9. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.